IT IS GENERALLY ASSUMED that the syndrome of severe, recurring ulcer disease associated with endocrine tumor(s) of the pancreas, originally described by Zollinger and Ellison, 37 results from abnormal secretion of gastrin from the pancreatic neoplasms. In contrast, since the very early reports, electron microscopy and, later, immunohistochemistry have revealed that in several instances these tumors were composed of glucagon-producing A-cells. We are reporting here two patients with severe ulcer disease and multiple islet cell adenomas of the pancreas, mostly composed of glucagon-producing cells. In both
IT IS GENERALLY ASSUMED that the syndrome of severe, recurring ulcer disease associated with endocrine tumor(s) of the pancreas, originally described by Zollinger and Ellison, 37 results from abnormal secretion of gastrin from the pancreatic neoplasms. In contrast, since the very early reports, electron microscopy and, later, immunohistochemistry have revealed that in several instances these tumors were composed of glucagon-producing A-cells. - 35 The clinical and pathologic implications of this unexpected association, however, have received little attention.
We are reporting here two patients with severe ulcer disease and multiple islet cell adenomas of the pancreas, mostly composed of glucagon-producing cells. In both cases a long follow-up and a systematic immunocytochemical investigation of all pancreatic tumors (both macroadenomas and microadenomas) illustrate the complex appearance of this pathologic condition. A review of the literature revealed 17 additional cases of multiple A-cell tumors of the pancreas.
Report of Two Cases

Case 1
The patient is a 63-year-old woman with a severe family history of duodenal ulcer affecting the father, two brothers, and one son. Her history included ulcer symptoms since 1946, when she was 25 years of age, and renal colics since 1962. Duodenal ulcer was diagnosed by x-ray examination in 1958, while emission of renal stones was first seen in 1965. In 1978, a Billroth II partial gastrectomy was performed for perforation of the duodenal ulcer. Seven months later, two stomal ulcers were found by endoscopic examination. A therapy with ^-antagonists improved the symptoms but had no effect on the persistence of ulcers. In 1983 the patient had right nephrolithotomy. On final admission in January 1984, she presented with perforation of a stomal ulcer, for which a total gastrectomy was performed. Pathologic examination of the surgical specimen showed stomal peptic ulcers and rugal hypertrophy of the gastric stump mucosa with parietal and argyrophil (Sevier-Munger) cell hyperplasia. She died in the third postoperative day of pulmonary embolism. Table 1 reports data on the patient's pertinent laboratory findings at different times during the course of her disease. In summary, circulating levels of gastrin only showed a modest elevation during the entire course of the disease and were not significantly influenced either by partial gastrectomy or by the secretin test. Gastric acid hypersecretion was apparent before and after partial gastric resection.
Postmortem examination revealed multiple adenomas of the pancreas (up to 0.8 cm in diameter), nodular hyperplasia of three parathyroid glands, and bilateral nodular adrenocortical hyperplasia (MEN-I). The pituitary gland was enlarged (measuring 17 X 10 X 10 mm), and the histologic pattern was consistent with diffuse hyperplasia predominantly affecting the basophil cells. No tumors were found in the duodenal mucosa, biliary tract, or lesser omental sac. Additional findings were thrombosis of femoral and iliac veins with a large embolus in the main pulmonary artery, nephrolithiasis of the right kidney with severe hydronephrosis, fatty liver, multinodular goiter, and one single papilloma of a pulmonic valve cusp. 
Case 2
A 42-year-old woman had a total gastrectomy and distal pancreatectomy in 1965. Her history of intractable ulcer disease despite repeated gastric operations began in 1958 and is described in detail in an early study. 31 The resected pancreatic tissue contained numerous tumors, two of which were distinctly larger than the others and measured 1.5 and 1.2 cm in diameter, respectively. Of interest is that these tumors, now easily identified at surgery by pancreatic manual examination, could not be found by the same maneuver during a previous operation performed three years after symptoms began. After total gastrectomy, the patient was well until 1977, when she presented mild diabetes, requiring 30 U per day of insulin. In 1982 a cholecystectomy was performed for acute suppurative cholecystitis that had developed in an atonic gallbladder filled with inspissated bile. During this operation, an extensive and diligent inspection of the pancreatic remnant, peripancreatic fat, duodenum, lesser omental sac, and biliary tract was done as requested for the localization of occult gastrinomas, 28 but no tumors were found. Ovaries were unremarkable. Pertinent laboratory findings of this case are reported in Table 1 . In summary, circulating gastrin levels were always in a range consistent with Zollinger-Ellison syndrome (ZES), and their significant increase induced by secretin was indicative of a gastrin-secreting tumor. 38 Pancreatic polypeptide (PP) and somatostatin blood concentrations were also elevated. In contrast, the normal glucagon levels allowed exclusion of the persistence of glucagonomas. A latent condition of hyperparathyroidism, not observed in 1974, was now disclosed by determinations of circulating calcium, phosphorus, and parathyroid hormone and pointed to a MEN-I syndrome. On x-ray examination, the size of the sella turcica (16 mm in length) was at the upper limit of normal. No symptoms of MEN-I or of ulcer disease were observed in 33 relatives of this patient.
Material and Methods
The entire pancreatic gland removed during the autopsy four hours after the patient's death was available in case 1. Twenty-four transverse sections of the gland, including all visible tumors, were collected roughly at equal intervals from the tail to the Vater's papilla. In case 2, the surgically resected specimen of the pancreas included the tail and the body of the gland. Six sections of the gland including the two macroadenomas were obtained. All tissue specimens were fixed in Bouin's fluid for 24 hours and embedded in paraffin. Serial sections were cut at 6 nm and one of them stained with hematoxylin and eosin for histologic evaluation and screening of specimens containing tumors. In the selected specimens, the indirect immunohistochemical procedure was performed with the use of the primary antisera listed in Table 2 . Either the indirect immunofluorescence method 7 or the peroxidase-antiperoxidase (PAP) technic 30 were used for visualization of the binding of primary antiserum. Controls included the use of antiserum adsorbed with an excess of the respective peptide in sections consecutive to those showing positive reaction.
The immunohistochemical results of all macroadenomas and microadenomas were recorded for each islet cell type in terms of major or minor cell population. The former was arbitrarily defined as an immunoreactive cell population accounting for more than 30% of the tumor cell population within individual neoplasms. A minimum size of 0.5 mm was regarded as a criterion for inclusion of adenomas in the study even if smaller aggregations of endocrine cells otherwise identical to adenomas for the histologic structure and the endocrine cell distribution were sometimes seen.
Results
Forty-three tumors were examined in case 1. Of these tumors, 20 were smaller than 1 mm in diameter, 17 were between 1 and 2 mm, and 6 were larger than 2 mm (Table 3 ). The adenomas were usually round and well demarcated, but a fibrous capsule was absent in 16 of them. Most microadenomas were located within the exocrine pancreatic lobules (Fig. \A) . They lacked topographic contiguity with ductal structures, which was occasionally noted only in larger adenomas. The histologic pattern 22 was gyriform in 34 tumors, mixed gyriform and solid in 8, and solid in 1 (Figs. \A and B) . The stroma was usually scanty. As shown in Table 3 , glucagon (A), insulin (B), and PP cells were detected by immunocytochemistry in most adenomas (Figs. \C-F) , while somatostatin (D) cells were less frequently represented. However, when only major cell populations were considered, A-cells were represented in 24 (55.8%) (Figs. \C and D) and PP-cells in 12 (27.9%) (Fig. \E) adenomas. In contrast, B-cells represented a major population in only one adenoma and D-cells in none. All tumors contained immunoreactive cells, and all but two were multihormonal.
The intratumoral distribution of different islet cell types was random and in no way reminiscent of the typical topographic distribution of normal islets. No gastrin-containing cells were found with any gastrin antisera employed. The frequency and size of the adenomas were higher in the tail region of the pancreas and tended to progressively decrease toward the head. No adenomas were found in the posterior area of the pancreatic head composed of PP-rich lobules.
Seventeen tumors were investigated in case 2. In four of them, the diameter was smaller than 1 mm, in three between 1 and 2 mm, in eight between 2 and 8 mm, and in two larger than 8 mm. Several tumors extended to intralobular septa, and an intimate topographic relation with duct structures was seen in six of them. Eleven neoplasms showed stromal fibrosis, which was often pronounced (Fig. 2A) . The histologic pattern was gyriform in three tumors, solid in six, and mixed in eight. Immunocytochemically, A-cells occurred in 16 adenomas and were a major population in 12 (70.6%). The latter included the two larger adenomas (Fig. 2B) , a finding at variance with the assumption that macroglucagonomas do not form in MEN-I pancreas. 18 Eleven tumors contained PP-cells, which were a major population in seven of them. B-and D-cells occurred less fre- 
FIG. 1. Case I. A (upper, left). Two typical islet cell microadenomas located within pancreatic exocrine acini. Hematoxylin and eosin (X38). B (upper, right). Predominance of gyriform histologic pattern with a focal solid area in a macroadenoma. Hematoxylin and eosin (X95). C (center, left). Three intralobular microadenomas showing a major population of glucagon-immunoreactive A-cells in two of them and mostly unreactive cells in the third one (the latter marked by arrowheads). Arrows point to normal islets containing A-cells. Peroxidase-antiperoxidase (X30). D (lower, left). Abundance of A-cells in an adenoma with a gyriform pattern. Peroxidase-antiperoxidase (X250). E (center, right
Hematoxylin and eosin (X30). B (upper, right). Glucagon immunofluorescence is present in most tumor cells of a macroadenoma(X210). C (lower, left). Immunofluorescent B-cells representing the minor cell population of an adenoma (XI70). D (lower, right).
Numerous D-cells are present in a normal islet trapped by the tumor, whereas the surrounding neoplastic cell clusters are completely unreactive. Nomarski's interference differential contrast optics, peroxidase-antiperoxidase (X150).
quently and always as a minor cell population (Figs. 2C  and D) , with the single exception of B-cells in one macroadenoma (Table 3 ). All tumors were multihormonal, except two adenomas that contained only A-cells and a third one that lacked immunorective cells. No gastrincontaining cells were identified.* PP-rich lobules were not included in the pancreatic specimens investigated in this case.
* Numerous cells of one macroadenoma reacted with one antigastrin antiserum 2 (no. 6, Table 2 ). This reaction was prevented by complement deprivation of the antiserum, 4 a finding indicating lack of specificity of the binding.
In both cases no relation was found between the occurrence of A-and PP-cells within individual tumors. When present together in the same adenoma, glucagon and PP immunoreactivities were found to be located in different cells. Glucagon immunoreactivity was found to be virtually identical after either the C-terminal-(02K) or the N-terminal-(05Y) directed antiserum.
Discussion
In this report, two cases of multiple islet cell adenomas with the predominance of glucagon-secreting Acells are presented. The neoplasms were associated with an ulcerogenic syndrome. A literature survey revealed oo without the typical ZES, was present in 13 patients. When measured, hypergastrinemia was found in all these patients as well as in one other patient with no ulcer symptoms. Symptomatic hypoglycemia was described in only four patients. These observations indicate a close relationship between multiple A-cell tumors and ulcer disease. In our patient 1, in spite of the severe clinical syndrome, the modest elevation of circulating gastrin levels, the negative secretin test, and the absence of gastrin-producing tumors at autopsy are at variance with the characteristic features of ZES. In some cases of normogastrinemic ulcerogenic syndrome, Chey and colleagues 6 have described a non-gastrin-secretogogue that is likely responsible for the ulcer diathesis. This possibility has to be considered in our patient. In case 2, hypergastrinemia persisted 17 years after total gastrectomy (i.e., 24 years after the onset of the ulcer symptoms). However, the source of hypergastrinemia was not identified at surgery, although an appropriate intraoperative inspection was performed. 28 In addition, gastrin-producing G-cells were not identified in the pancreatic tumors, despite the use of different antigastrin antisera, including the antiserum 2064, which reacts with all known forms of gastrins. In this regard, it is noteworthy that gastrin-containing G-cells were never found in the pancreatic tumors of the six cases previously investigated by immunocytochemistry (Table 4) , although in two patients they were identified in extrapancreatic sites (metastatic lymph nodes 17 and duodenal gastrinomas, 18 respectively). Persistence of hypergastrinemia without macroscopic evidence of a gastrinoma is a common finding in patients with MEN-I. 18, 32 Explanations offered for this discrepancy include the following: (1) occult gastrinoma in the pancreatic remnants after distal pancreatectomy 18 ; (2) duodenal microgastrinomas escaping macroscopic examination 2438 ; (3) occult metastases in the liver 13 ; (4) parathyroid origin of gastrin 5 ; (5) tumor production of an unknown gastrin-releasing factor inducing inappropriate gastrin secretion from the antral G-cells. 18 None of these explanations has obtained conclusive evidence. In particular, points (3) and (5) cannot be applied in our patient 2, because the long observation period reasonably rules out metastases, while hypergastrinemia persisted despite total gastrectomy.
In full agreement with previous reports (Table 4) , a glucagonoma syndrome was not present in our patients. In case 2 studies of glucagon secretion 17 years after distal pancreatic resection showed normal circulating levels after fasting or arginin stimulation. These findings may indicate either the absence of glucagon-producing 160 BORDl ET AL.
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tumors in the remnant pancreatic head or their regression after pancreatectomy. Glucagon hypersecretion also could not be considered responsible for the patient's diabetes, a disorder occurring in three other cases listed in Table 4 . Glucagon secretion was evaluated in six previous patients with multiple A-cell tumors, 1012   -21   -23   -2536 showing abnormal elevations in 5 cases.
MEN-I polyglandular involvement was overt in our case 1 and latent in case 2. When investigated, MEN-I has been found in all previous cases of multiple A-cell tumors ( Table 4 ). The incidence of these tumors in patients with MEN-I is controversial because they were frequent in one study 18 and rare in other studies. In our patients, glucagon cell adenomas also exhibit numerous PP-containing cells, a finding consistent with previous observations. 318, 26 In both cases the tumors were located in the glucagon-rich, PP-poor part of the pancreas (of dorsal embryological origin). In case 1, in which the entire pancreas could be examined, no adenomas were detected in the PP-rich and glucagon-poor region of the pancreas (of ventral embryologic origin).
The multiple pancreatic tumors of our patients did not show histologic or clinical features of malignancy. However, lymph node metastases were found in seven previous cases (Table 4) . Metastatic glucagonoma to the liver has been reported in two more cases of ZES not included in Table 4 because of the limited information provided on the primary tumors. 8, 33 The factors responsible for the selective proliferation and/or differentiation of glucagon-producing cells in the genetically determined tumors of some patients with MEN-I are unknown. A possible role for gastrin 1, 20 seems to be contradicted by the findings of our patients in which either the elevation of gastrin was modest (case 1) or glucagon-secreting adenomas were no longer present despite the persistence of hypergastrinemia (case 2). On the basis of the present study, it is recommended that in patients and MEN-I with ulcer disease, data on glucagon secretion are obtained in addition to those that can be furnished by other markers 14, 24 for the detection and thorough evaluation of the pancreatic adenopathy.
